{"id":311,"date":"2024-06-08T13:37:13","date_gmt":"2024-06-08T13:37:13","guid":{"rendered":"https:\/\/dev.campbellneurosciences.com\/?page_id=311"},"modified":"2024-06-08T13:37:13","modified_gmt":"2024-06-08T13:37:13","slug":"therapeutic-solutions-international-files-comprehensive-campbell-platform-patent-for-stem-cell-immunotherapyof-schizophrenia","status":"publish","type":"page","link":"https:\/\/campbellneurosciences.com\/index.php\/therapeutic-solutions-international-files-comprehensive-campbell-platform-patent-for-stem-cell-immunotherapyof-schizophrenia\/","title":{"rendered":"Therapeutic Solutions International Files Comprehensive Campbell Platform\u2122 Patent for Stem Cell Immunotherapyof Schizophrenia"},"content":{"rendered":"

[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” next_background_color=”#ffffff” admin_label=”Hero” _builder_version=”4.24.3″ use_background_color_gradient=”on” background_color_gradient_type=”circular” background_color_gradient_direction_radial=”top right” background_color_gradient_stops=”rgba(255,255,255,0) 20%|rgba(1,77,183,0.9) 100%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”rgba(255,255,255,0)” background_color_gradient_start_position=”20%” background_color_gradient_end=”rgba(1,77,183,0.9)” background_image=”https:\/\/campbellneurosciences.com\/wp-content\/uploads\/2024\/06\/shutterstock_1028494843-scaled.jpg” custom_padding=”110px|0px|49px|0px|false|false” custom_padding_tablet=”50px||50px||true” custom_padding_phone=”|||” bottom_divider_style=”asymmetric” bottom_divider_height=”50px” bottom_divider_flip=”horizontal” bottom_divider_height_tablet=”90px” bottom_divider_height_phone=”80px” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ custom_width_px=”1280px” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”2_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.24.3″ text_font=”Montserrat||||||||” text_text_color=”rgba(255,255,255,0.7)” text_font_size=”20px” text_line_height=”1.8em” header_font=”Montserrat|700|||||||” header_font_size=”44px” header_line_height=”1.4em” header_6_font=”Montserrat|600||on|||||” header_6_text_color=”rgba(255,255,255,0.7)” header_6_font_size=”16px” header_6_letter_spacing=”2px” header_6_line_height=”1.5em” background_layout=”dark” max_width=”780px” custom_margin=”-65px|||||” text_font_size_tablet=”” text_font_size_phone=”15px” text_font_size_last_edited=”on|phone” header_font_size_tablet=”” header_font_size_phone=”28px” header_font_size_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n

Campbell Neurosciences, inc.<\/span><\/h1>\n

Committed to establishing a biological basis for diagnosis and treatment of suicide and its causes, including Schizophrenia and other mental health disorders, thereby eliminating the stigma of the disease.<\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”-31px|auto||auto||” custom_padding=”0px|||||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n

\n

Therapeutic Solutions International Files Comprehensive Campbell Platform\u2122 Patent for Stem Cell Immunotherapy
of Schizophrenia<\/strong><\/span><\/h2>\n

Campbell Neurosciences Division Continues Groundbreaking Work Based on Treating Suicide as a Biological Disease<\/em><\/span><\/h4>\n
\n

OCEANSIDE, Calif.<\/span>,\u00a0<\/span>Sept. 14, 2020<\/span>\u00a0<\/span>\/PRNewswire\/ \u2014\u00a0Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today filing of a landmark patent, with over 1000 claims, covering stem cell based immunotherapy of schizophrenia, one of the significant causes of suicide.\u00a0 The patent, based on years of biochemical, neurological and cellular research by the inventors covers utilization of various stem cell types, as well as cellular immunotherapies, nutraceuticals, and small molecules, for reducing symptoms and increasing treatment responsiveness in schizophrenic patients.\u00a0<\/p>\n

\u201cSchizophrenia, despite affecting approximately 1% of the population, is still treated in a very empirical manner with little understanding of the molecular mechanisms of the disease or the currently used treatments\u201d said\u00a0<\/span>Kalina O\u2019Conner<\/span>, Director of Campbell Neurosciences and co-inventor of the patent. \u201cWe are proud to have developed a novel, science-based, platform for therapeutic intervention which is grounded in objective assessment and intervention methods.\u201d<\/p>\n

The Campbell Platform\u2122<\/span>\u00a0is an extension of earlier work described by the Company as the Campbell Score\u2122<\/span>, \u00a0in which inflammatory markers, exosomes, and imaging technologies are initially used to provide an integrative means of evaluating disease status.\u00a0 Once the unique aspects of each patient\u2019s disease are understood, a personalized approach is developed to address their own unique needs.<\/p>\n

\u201cThe JadiCell has been demonstrated to possess exceptional anti-inflammatory and immune modulatory activity.\u00a0 We are extremely excited to apply these properties to the area of neurology\u201d said Dr.\u00a0<\/span>Amit Patel<\/span>, co-inventor of the patent, and inventor of the JadiCell.\u00a0 \u201cHaving exclusively licensed certain neurologically related aspects of the JadiCell Universal donor stem cell technology to the Company, I am excited about these new developments and strongly support the current work in progress associated with suicide, brain injury, and chronic traumatic encephalopathy.\u201d<\/p>\n

In\u00a0<\/span>December 2018<\/span>\u00a0<\/span>Therapeutic Solutions International signed an agreement with Jadi Cell LLC for licensing of the JadiCell universal donor adult stem cell, as covered in US Patent No.: 9,803,176 B2 for use in Chronic Traumatic Encephalopathy (CTE), and Traumatic Brain Injury (TBI)1<\/sup>.\u00a0\u00a0<\/p>\n

\u201cIt is truly amazing to see the dedication of our Team and Scientific Advisors at rapidly translating ideas to patents, to preclinical research and to INDs\u201d said\u00a0<\/span>Timothy Dixon<\/span>, President and CEO of the Company, as well as co-inventor of the recently filed patent.\u00a0 \u201cBy working with scientific\/medical leaders, such as Dr.\u00a0<\/span>Amit Patel<\/span>, the first person to inject stem cells into the human heart, we are always pushing the limits of science and coming up with approaches that one day will help patients.\u00a0 Being Suicide Prevention Month, we especially remember the memory of\u00a0<\/span>Kathleen Campbell<\/span>, mother of\u00a0<\/span>Kalina O\u2019Conner<\/span>, a victim of suicide in whose name we started Campbell Neurosciences.\u201d<\/p>\n

About Therapeutic Solutions International, Inc.
<\/b>Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company\u2019s corporate website is\u00a0<\/span>www.therapeuticsolutionsint.com<\/a>, and our public forum is\u00a0<\/span>https:\/\/board.therapeuticsolutionsint.com\/<\/a>\u00a0<\/p>\n

1<\/sup>\u00a0<\/b>https:\/\/www.globenewswire.com\/news-release\/2018\/12\/10\/1664452\/0\/en\/Therapeutic-Solutions-International-Signs-Agreement-for-Licensing-Jadi-Cell-s-Universal-Donor-Adult-Stem-Cell-Product-for-Chronic-Traumatic-Encephalopathy-and-Traumatic-Brain-Injur.html<\/a><\/p>\n

 <\/p>\n<\/header>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Campbell Neurosciences, inc. Committed to establishing a biological basis for diagnosis and treatment of suicide and its causes, including Schizophrenia and other mental health disorders, thereby eliminating the stigma of the disease. Therapeutic Solutions International Files Comprehensive Campbell Platform\u2122 Patent for Stem Cell Immunotherapyof Schizophrenia Campbell Neurosciences Division Continues Groundbreaking Work Based on Treating Suicide […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-311","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/comments?post=311"}],"version-history":[{"count":2,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/311\/revisions"}],"predecessor-version":[{"id":313,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/311\/revisions\/313"}],"wp:attachment":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/media?parent=311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}